It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
As spaceflight becomes more common with commercial crews, blood-based measures of crew health can guide both astronaut biomedicine and countermeasures. By profiling plasma proteins, metabolites, and extracellular vesicles/particles (EVPs) from the SpaceX Inspiration4 crew, we generated “spaceflight secretome profiles,” which showed significant differences in coagulation, oxidative stress, and brain-enriched proteins. While >93% of differentially abundant proteins (DAPs) in vesicles and metabolites recovered within six months, the majority (73%) of plasma DAPs were still perturbed post-flight. Moreover, these proteomic alterations correlated better with peripheral blood mononuclear cells than whole blood, suggesting that immune cells contribute more DAPs than erythrocytes. Finally, to discern possible mechanisms leading to brain-enriched protein detection and blood-brain barrier (BBB) disruption, we examined protein changes in dissected brains of spaceflight mice, which showed increases in PECAM-1, a marker of BBB integrity. These data highlight how even short-duration spaceflight can disrupt human and murine physiology and identify spaceflight biomarkers that can guide countermeasure development.
Here the authors report spaceflight secretome profiles by integrating plasma proteome, metabolome, and extracellular vesicles/particles proteome from the SpaceX Inspiration4 crew, which showed differences in coagulation, oxidative stress, and brain-enriched proteins.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details













1 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
2 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
3 Weill Cornell Medicine, The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, Tri-Institutional Biology and Medicine program, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
4 Weill Cornell Medicine, Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Drukier Institute for Children’s Health, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Babes-Bolyai University, Department of Molecular Biology and Biotechnology, Center of Systems Biology, Biodiversity and Bioresources, Faculty of Biology and Geology, Cluj-Napoca, Romania (GRID:grid.7399.4) (ISNI:0000 0004 1937 1397)
5 Weill Cornell Medicine, Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Drukier Institute for Children’s Health, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Department of Pharmacology, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
6 Florida State University, Department of Nutrition & Integrative Physiology, Tallahassee, USA (GRID:grid.255986.5) (ISNI:0000 0004 0472 0419)
7 Children’s Hospital of Philadelphia, Center of Mitochondrial and Epigenomic Medicine, Philadelphia, USA (GRID:grid.239552.a) (ISNI:0000 0001 0680 8770)
8 Broad Institute of MIT and Harvard, Stanley Center for Psychiatric Research, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); NASA Ames Research Center, KBR, Space Biosciences Division, Moffett Field, USA (GRID:grid.481680.3) (ISNI:0000 0004 0634 8729)
9 Weill Cornell Medicine, Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Drukier Institute for Children’s Health, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Inc., Seer, Redwood City, USA (GRID:grid.5386.8)
10 Weill Cornell Medicine, Department of Pharmacology, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
11 Inc., Seer, Redwood City, USA (GRID:grid.471410.7)
12 King Faisal Specialist Hospital & Research Centre, Department of Neuroscience, Jeddah, Saudi Arabia (GRID:grid.415310.2) (ISNI:0000 0001 2191 4301)
13 Space Exploration Technologies Corporation (SpaceX), Hawthorne, USA (GRID:grid.499343.0) (ISNI:0000 0004 4672 1890)
14 Loma Linda University Health, Department of Basic Sciences, Division of Biomedical Engineering Sciences (BMES), Loma Linda, USA (GRID:grid.429814.2)
15 Weill Cornell Medicine, Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Drukier Institute for Children’s Health, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Weill Cornell Medicine, Meyer Cancer Center, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
16 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, Tri-Institutional Biology and Medicine program, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The Feil Family Brain and Mind Research Institute, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, WorldQuant Initiative for Quantitative Prediction, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)